---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-039147"
form_type: "8-K"
ticker: "JAZZ"
cik: "0001232524"
company_name: "Jazz Pharmaceuticals plc"
filed_at: "2026-05-29T20:05:00+00:00"
generated_at: "2026-05-29T20:06:15.596551+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Director Anne O'Riordan not standing for re-election at Jazz's 2026 annual meeting

## Summary
- Class III director Anne O'Riordan will not seek re-election at the 2026 annual meeting, continuing board refreshment.
- O'Riordan's decision was not due to any dispute or disagreement with the company or board.
- Board will continue to evaluate composition; no immediate replacement announced.

## SEC filing metadata
- accession: 0001628280-26-039147
- form_type: 8-K
- ticker: JAZZ
- cik: 0001232524
- company_name: Jazz Pharmaceuticals plc
- filed_at: 2026-05-29T20:05:00+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1232524/000162828026039147/0001628280-26-039147-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1232524/000162828026039147/jazz-20260525.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-039147
- JSON: https://secwatch.observer/filing/0001628280-26-039147.json
- Plain text: https://secwatch.observer/filing/0001628280-26-039147.txt

## Source-grounded claims
- claim_id: 6da41569bd
  claim: Anne O'Riordan departed as Director at Jazz Pharmaceuticals plc.
  evidence_excerpt: On May 25, 2026, Anne O’Riordan, a Class III director whose term expires at the Jazz Pharmaceuticals plc (the “Company”) 2026 annual meeting of shareholders, has informed the board of directors (the “Board”) that she will not stand for re-election.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1232524/000162828026039147/0001628280-26-039147-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.